Saroglitazar also reduced fasting insulin levels in DIAMOND mice (Fig. 1D) and was reflected in a significant decrease in insulin resistance as measured by HOMA-IR (homeostatic model Assessment for insulin resistance) (Fig. 1E). This evidence concerns the gene INS and Insulin resistance.